LymphoidStructureMiner: AI-based exploration of the immunological contexture of lymphoid structures in translational research
Dauer: 24 Monate, Fördersumme: € 480.236
Improvement of taste perception by homoeriodictyol in cancer patients after chemotherapy
Dauer: 60 Monate, Fördersumme: € 362.540
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
Dauer: 60 Monate, Fördersumme: € 799.350
Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
Dauer: 48 Monate, Fördersumme: € 799.510
PHARMACOSCOPY: Breaking resistance of refractory blood cancers through ex vivo automated image-based analysis of drug action
Dauer: 46 Monate, Fördersumme: € 904.000
Therapeutic targeting of EGFR in colorectal cancer as a novel approach to predict and enhance tumor antigenicity and response to checkpoint inhibitors
Dauer: 54 Monate, Fördersumme: € 999.500